Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems Opens Australian IPO

NEW YORK, Aug. 30 (GenomeWeb News) - Proteome Systems announced last week the opening of its AU$20 million initial public offering on the Australian Stock Exchange. The offer price, said Proteome Systems, gives the company a market capitalization of AU$120 million.

 

The size of the IPO is significantly less than Proteome Systems had initial hoped for. As reported earlier this year by ProteoMonitor, GenomeWeb News' sister publication, the company had originally planned to raise AU$45 million, a figure later cut to AU$35 million.

 

According to Proteome Systems, Patersons Securities is underwriting the offering.

 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.